UiPath Inc.

NYSE (USD): UiPath Inc. (PATH)

Last Price

12.57

Today's Change

+0.21 (1.69%)

Day's Change

12.33 - 12.66

Trading Volume

4,271,784

News and Blogs

No result.

Discussions
Be the first to like this. Showing 2 of 2 comments

sammofee

ada potential

2021-08-21 21:40

Wong137

Shares of Uipath (NYSE: ) are down nearly 15% in premarket trading Thursday after the company released a weaker-thanexpected Q1 revenue forecast.
The software maker reported Q4 adjusted EPS of 5c, well above the analyst consensus of 2.6c per share. Total revenue in the quarter
came in at $289.7 million.
For the first quarter, UiPath expects revenue in the range of $223 million to $225 million, missing the consensus estimates of $246.4
million. The company expects Q1 adjusted operating loss in the range of $25 million to $30 million.
"We have built a global business that serves customers in more than 115 countries, including countries across eastern Europe and
Russia," said the company's CEO Daniel Dines.
Looking ahead, we feel confident in our market-leading position in automation and prospects for future growth at scale but believe it is
prudent at this time to factor both our European exposure and go-to-market leadership transition into the financial outlook we are
providing this afternoon.
Credit Suisse analyst Phil Winslow believes PATH's guidance reflects significant conservatism. The analyst slashed the price target to
$57.50 from the prior $75.00.
To further frame the conservatism in terms of new vs. expansion business, FY2023 ARR guidance excluding headwinds would imply
$0 ARR contribution from new customers and DBNRR declining from 145% to ~134% "despite maintaining a best-in-class range vs.
153% exiting FY2020. We reiterate our thesis that the market opportunity in terms of global automatable wages is both sizable and
largely untapped, we believe that UiPath, with the only purpose-built, end-to-end hyperautomation platform, is leading the paradigm
shift toward the fully-automated enterprise," Winslow said in a client note.
Cowen analyst Bryan Bergin sees many moving parts in the PATH story after EPS.

2022-03-31 11:01

Post a Comment